# Elacestrant in Preoperative Setting, a Window of Opportunity Study

> **NCT04797728** · EARLY_PHASE1 · COMPLETED · sponsor: **SOLTI Breast Cancer Research Group** · enrollment: 23 (actual)

## Conditions studied

- Breast Cancer
- Hormone Receptor Positive Breast Carcinoma

## Interventions

- **DRUG:** Elacestrant

## Key facts

- **NCT ID:** NCT04797728
- **Lead sponsor:** SOLTI Breast Cancer Research Group
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-09
- **Primary completion:** 2022-02-08
- **Final completion:** 2022-02-25
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04797728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04797728, "Elacestrant in Preoperative Setting, a Window of Opportunity Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04797728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*